Vascular Access

SAVE-US Pivotal Trial Receives Positive Clinical Results

No comments
SAVE-US Pivotal Trial Receives Positive Clinical Results

Register to receive a free Vascular Access Devices and Accessories Market Report Suite for US  synopsis and brochure On June 4th 2019, Bluegrass Vascular Technologies, a private medical company specializing in vascular access devices and procedures, has announced successful enrolment of the SAVE-US (Surfacer® System to Facilitate Access in VEnous Occlusions – United States) trial, which tested the safety and accuracy of SAVE-US.

iData ResearchSAVE-US Pivotal Trial Receives Positive Clinical Results
read more

Saranas’ Early Bird Endovascular Device Gains FDA De Novo Designation

No comments
Saranas’ Early Bird Endovascular Device Gains FDA De Novo Designation

Register to receive a free Vascular Access Devices and Accessories Market Report Suite for US  synopsis and brochure Saranas, a developer of internal bleeding medical devices, has announced that the U.S. Food and Drug Administration (FDA) has granted de novo designation to their Early Bird endovascular bleed monitoring system. Initially invented at the Texas Heart Institute,

iData ResearchSaranas’ Early Bird Endovascular Device Gains FDA De Novo Designation
read more

FDA Approves Patent Ductus Arteriosus Closure Device

No comments
FDA Approves Patent Ductus Arteriosus Closure Device

Register to receive a free Vascular Access Devices and Accessories Market Report Suite for US  synopsis and brochure Abbott has announced the FDA approval of the Amplatzer Piccolo occluder, a closure device for the treatment of patent ductus arteriosus. This device differs from existing closure options as it can treat premature babies with the defect who

iData ResearchFDA Approves Patent Ductus Arteriosus Closure Device
read more

Interrad Medical Announces Agreement with Vygon to Distribute SecurAcath in France

No comments
Interrad Medical Announces Agreement with Vygon to Distribute SecurAcath in France

Register to receive a free Vascular Access Devices and Accessories Market Report Suite for US  synopsis and brochure Interrad Medical, a privately held medical device company, announces an agreement with Vygon to distribute the SecurAcath Subcutaneous Catheter Securement Device in France. “As we continue to expand global distribution, we are very excited to be able to

iData ResearchInterrad Medical Announces Agreement with Vygon to Distribute SecurAcath in France
read more

B. Braun Launches Safety Engineered Port Access Needle

No comments
B. Braun Launches Safety Engineered Port Access Needle

Register to receive a free Vascular Access Devices and Accessories Market Report Suite for US 2018-2024 synopsis and brochure B. Braun Medical Inc. has introduced its Surecan™ Safety II Port Access Needles, a safety-engineered needle for accessing implanted intravenous ports. The safety mechanism offers a unique visual confirmation when successfully engaged. The non-coring port access needles are

iData ResearchB. Braun Launches Safety Engineered Port Access Needle
read more

Top Becton Dickinson Competitors in the U.S.

No comments
Top Becton Dickinson Competitors in the U.S.

Register to receive a free U.S. Market Report Suite for Infusion Therapy Device –MedSuite report synopsis and brochure Becton Dickinson’s (BD) operations consist of two major business segments, BD Medical and BD Life Sciences. This article will focus solely on the BD Medical segment, which comprises four organizational units: Diabetes Care, Medication and Procedural Solutions, Medication Management

iData ResearchTop Becton Dickinson Competitors in the U.S.
read more

AngioDynamics Provides Updates on Vascular Access Businesses

No comments
AngioDynamics Provides Updates on Vascular Access Businesses

Register to receive a free Vascular Access Devices and Accessories Market Report Suite for US 2018-2024 synopsis and brochure AngioDynamics, Inc., a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology, acknowledged a recent, favorable U.S. District Court ruling that impacts its Vascular Access business. In May of 2017, AngioDynamics

iData ResearchAngioDynamics Provides Updates on Vascular Access Businesses
read more

BD Acquires TVA Medical

No comments
BD Acquires TVA Medical

Register to receive a free Vascular Access Devices and Accessories Market Report Suite for US 2018-2024 synopsis and brochure BD (Becton, Dickinson and Company), a leading global medical technology company, announced it has completed the acquisition of TVA Medical, Inc., a company that develops minimally invasive vascular access solutions for patients with chronic kidney disease requiring hemodialysis.

iData ResearchBD Acquires TVA Medical
read more

Access Scientific Completes Study Demonstrating Superior Anti-Thrombotic Properties of POWERWAND Midlines and Extended Dwell Catheters

No comments
Access Scientific Completes Study Demonstrating Superior Anti-Thrombotic Properties of POWERWAND Midlines and Extended Dwell Catheters

Register to receive a free Vascular Access Devices and Accessories Market Report Suite for US 2018-2024 synopsis and brochure Access Scientific, LLC announced the completion of an in vivo study demonstrating the superior anti-thrombotic (i.e., anti-clotting) property of its unique intravascular catheter material, ChronoFlex C® with BioGUARD™ technology. The study found that ChronoFlex C with BioGUARD demonstrates

iData ResearchAccess Scientific Completes Study Demonstrating Superior Anti-Thrombotic Properties of POWERWAND Midlines and Extended Dwell Catheters
read more

CorMedix Announces Changes to Lock-It-100, Phase 3 Clinical Trial in Hemodialysis Patients with CVCs

No comments
CorMedix Announces Changes to Lock-It-100, Phase 3 Clinical Trial in Hemodialysis Patients with CVCs

Register to receive a free Vascular Access Devices and Accessories Market Report Suite for US 2018-2024 synopsis and brochure CorMedix Inc., a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, announced that it is in negotiations with its contract research organization (“CRO”) regarding certain remediation efforts

iData ResearchCorMedix Announces Changes to Lock-It-100, Phase 3 Clinical Trial in Hemodialysis Patients with CVCs
read more